MAPT and Parkinson disease: In particular, a deeper investigation of the signaling pathways involving α-syn, neuroinflammation, Aβ and Tau pathology, NfL, and axonal injury and degeneration may provide unprecedented information on PD pathophysiology and contribute substantially to the biomarker discovery process.